David Katz Sorrento Therapeutics, Inc. Transaction History

Matrix Asset Advisors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$6.17 - $18.82 $308,500 - $941,000	-50,000 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$1.45 - $4.17 $14,500 - $41,700	-10,000 Reduced 16.67%	50,000 $169,000
Q2 2018 Aug 13, 2018	BUY	$4.75 - $8.0 $47,500 - $80,000	10,000 Added 20.0%	60,000 $432,000
Q1 2018 May 15, 2018	SELL	$4.5 - $9.95 $99,000 - $218,899	-22,000 Reduced 30.56%	50,000 $258,000
Q2 2017 Aug 09, 2017	BUY	N/A	50,000 Added 227.27%	72,000 $144,000
Q4 2016 Feb 08, 2017	SELL	N/A	-1,128 Reduced 4.88%	22,000 $108,000
Q4 2013 Feb 07, 2014	SELL	N/A	-1,500 Reduced 6.09%	23,128 $187,000
Q3 2013 Nov 08, 2013	BUY	N/A	24,628	24,628 $236,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.